Cell signaling and nuclear receptors: New opportunities for molecular pharmaceuticals in liver disease

Molecular Pharmaceutics

Volumn 5, Issue 1, 2008, Pages 17-34

  Staudinger, Jeff L ^a   Lichti, Kristin ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Liver; Nuclear receptors; Phosphorylation; Signal transduction; Therapeutic agents

Indexed keywords

CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; FARNESOID X RECEPTOR; FIBROBLAST GROWTH FACTOR; HEPATIC NUCLEAR FACTOR 4ALPHA; LIVER RECEPTOR HOMOLOG 1; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; NUCLEAR FACTOR; NUCLEAR RECEPTOR COACTIVATOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PIOGLITAZONE; PREGNANE X RECEPTOR; PROTEIN P160; ROSIGLITAZONE; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TAMOXIFEN; UNCLASSIFIED DRUG;

BREAST CANCER; DRUG MECHANISM; HUMAN; LIVER; LIVER DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; DRUGS, INVESTIGATIONAL; HUMANS; LIVER DISEASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 39749189427     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp700098c     Document Type: Review

References (211)